CEL-SCI Management

Management criteria checks 3/4

CEL-SCI's CEO is Geert Kersten, appointed in Jan 1989, has a tenure of 35.92 years. total yearly compensation is $1.03M, comprised of 62% salary and 38% bonuses, including company stock and options. directly owns 1.89% of the company’s shares, worth $879.28K. The average tenure of the management team and the board of directors is 15.2 years and 8.3 years respectively.

Key information

Geert Kersten

Chief executive officer

US$1.0m

Total compensation

CEO salary percentage62.0%
CEO tenure35.9yrs
CEO ownership1.9%
Management average tenure15.2yrs
Board average tenure8.3yrs

Recent management updates

Recent updates

Market Sentiment Around Loss-Making CEL-SCI Corporation (NYSEMKT:CVM)

Apr 29
Market Sentiment Around Loss-Making CEL-SCI Corporation (NYSEMKT:CVM)

We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth

Mar 01
We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth

What Does CEL-SCI's (NYSEMKT:CVM) CEO Pay Reveal?

Jan 25
What Does CEL-SCI's (NYSEMKT:CVM) CEO Pay Reveal?

Breakeven On The Horizon For CEL-SCI Corporation (NYSEMKT:CVM)

Dec 21
Breakeven On The Horizon For CEL-SCI Corporation (NYSEMKT:CVM)

CEO Compensation Analysis

How has Geert Kersten's remuneration changed compared to CEL-SCI's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$29m

Mar 31 2024n/an/a

-US$30m

Dec 31 2023n/an/a

-US$31m

Sep 30 2023US$1mUS$637k

-US$32m

Jun 30 2023n/an/a

-US$34m

Mar 31 2023n/an/a

-US$35m

Dec 31 2022n/an/a

-US$37m

Sep 30 2022US$1mUS$616k

-US$38m

Jun 30 2022n/an/a

-US$37m

Mar 31 2022n/an/a

-US$36m

Dec 31 2021n/an/a

-US$37m

Sep 30 2021US$854kUS$580k

-US$37m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$35m

Dec 31 2020n/an/a

-US$33m

Sep 30 2020US$3mUS$756k

-US$30m

Jun 30 2020n/an/a

-US$30m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019n/an/a

-US$29m

Sep 30 2019US$5mUS$511k

-US$22m

Jun 30 2019n/an/a

-US$32m

Mar 31 2019n/an/a

-US$26m

Dec 31 2018n/an/a

-US$24m

Sep 30 2018US$3mUS$558k

-US$32m

Compensation vs Market: Geert's total compensation ($USD1.03M) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Geert's compensation has been consistent with company performance over the past year.


CEO

Geert Kersten (65 yo)

35.9yrs

Tenure

US$1,027,965

Compensation

Mr. Geert R. Kersten, Esq., has been the Chief Executive Officer at CEL-SCI Corporation since February 1995 and served as its Chief Financial Officer. Mr. Kersten joined CEL-SCI Corporation in 1987. Mr. Ke...


Leadership Team

NamePositionTenureCompensationOwnership
Geert Kersten
CEO, Treasurer & Director35.9yrsUS$1.03m1.89%
$ 879.3k
Patricia Prichep
Chief Financial and Operations Officer & Corporate Secretary30.8yrsUS$516.73k0.38%
$ 175.2k
Eyal Talor
Chief Scientific Officer15.2yrsUS$584.23k0.19%
$ 86.6k
Daniel Zimmerman
Senior Vice President of Research & Cellular Immunology15.1yrsUS$46.08k0.19%
$ 87.8k
John Cipriano
Senior Vice President of Regulatory Affairs15.2yrsUS$326.53k0.099%
$ 46.1k
Giovanni Selvaggi
Acting Chief Medical Officerless than a yearno datano data

15.2yrs

Average Tenure

73yo

Average Age

Experienced Management: CVM's management team is seasoned and experienced (15.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Geert Kersten
CEO, Treasurer & Director36yrsUS$1.03m1.89%
$ 879.3k
Robert Watson
Independent Chairman of the Board7yrsUS$135.83k0.038%
$ 17.8k
Mario Gobbo
Directorless than a yearno datano data
Bruno Baillavoine
Independent Director9.5yrsUS$133.33k0.0094%
$ 4.4k

8.3yrs

Average Tenure

69yo

Average Age

Experienced Board: CVM's board of directors are considered experienced (8.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 11:59
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CEL-SCI Corporation is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew FeinChardan Capital Markets, LLC
Christian OrqueraFirst Berlin Equity Research GmbH
Vernon BernardinoH.C. Wainwright & Co.